These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9254771)
1. ELITE study raises losartan's profile in heart failure therapy debate. S Afr Med J; 1997 Jun; 87 Suppl 3():C182. PubMed ID: 9254771 [No Abstract] [Full Text] [Related]
2. Losartan versus captopril in elderly patients with heart failure. Ball SG Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338 [No Abstract] [Full Text] [Related]
3. Losartan versus captopril in elderly patients with heart failure. Jensen BV; Nielsen SL Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335 [No Abstract] [Full Text] [Related]
4. [Medical angiotensin II-receptor blockade in hypertension and heart failure]. van Zwieten PA; Lie KI Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129 [No Abstract] [Full Text] [Related]
5. Losartan versus captopril in elderly patients with heart failure. Sechi LA; Catena C; Bartoli E Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337 [No Abstract] [Full Text] [Related]
6. Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension? Beevers DG; Lip GY J Hum Hypertens; 1997 Jun; 11(6):329-30. PubMed ID: 9249225 [No Abstract] [Full Text] [Related]
7. [Angiotensin II antagonist for heart insufficiency]. Z Kardiol; 1997 Jun; 86(6 Suppl):1-8. PubMed ID: 9259867 [No Abstract] [Full Text] [Related]
8. Angiotensin II antagonism: a new avenue of hypertension management. Gavras H Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108 [TBL] [Abstract][Full Text] [Related]
9. Losartan versus captopril in elderly patients with heart failure. Fournier A; Achard JM; Fernandez LA Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336 [No Abstract] [Full Text] [Related]
10. Angiotensin receptor antagonists as a treatment for hypertension. MacFadyen RJ; Reid JL J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690 [No Abstract] [Full Text] [Related]
11. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Krasnikova TL Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692 [No Abstract] [Full Text] [Related]
12. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure]. Rakugi H; Ogihara T Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure. Dickstein K; Gottlieb S; Fleck E; Kostis J; Levine B; DeKock M; LeJemtel T J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263 [TBL] [Abstract][Full Text] [Related]
14. The CHARM programme raises the profile of candesartan cilexetil in the treatment of chronic health failure. Cardiovasc J S Afr; 2004; 15(1):42-3. PubMed ID: 15095753 [No Abstract] [Full Text] [Related]
15. Losartan: a new antihypertensive drug. Dubois M; Wilson TW Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121 [TBL] [Abstract][Full Text] [Related]
16. Losartan for hypertension. Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693 [No Abstract] [Full Text] [Related]
17. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist]. Kjeldsen SE; Omvik P Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056 [TBL] [Abstract][Full Text] [Related]
18. [Angiotensin receptor antagonist for therapy of patients with hypertension]. Rakugi H; Ogihara T Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426 [TBL] [Abstract][Full Text] [Related]